Understanding liver fibrosis: Insights from Alagille syndrome
More information: Jan Mašek et al, Jag1 insufficiency alters liver fibrosis via T cell and hepatocyte differentiation defects ...
pharmaphorum10d
Ipsen's Alagille drug backed by CHMP again, with new name
In unusual circumstances, Ipsen has been given the green light for its odevixibat drug for severe itching (pruritus) in patients with rare liver disease Alagille syndrome (ALGS) in the EU – for ...
pharmaphorum6mon
Ipsen crosses EU finish line with Alagille syndrome drug
in patients with the rare liver disease Alagille syndrome (ALGS). Kayfanda (odevixibat) is labelled in the EU to treat cholestatic pruritus – itching caused by impaired bile formation or flow ...